MUSTANG BIO, INC. Financing Cash Flow
MUSTANG BIO, INC. (MBIO) reported Financing Cash Flow of -$141.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$141.00K.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $7.14M, a 604.64% increase year-over-year.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for fiscal 2025 was $14.53M, a 28.95% increase from fiscal 2024.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for fiscal 2024 was $11.27M.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for fiscal 2023 was -$26.08M, a 176.58% decline from fiscal 2022.
- MUSTANG BIO, INC. net cash provided by (used in) financing activities for fiscal 2022 was $34.06M, a 51.93% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 10 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$141.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$141.00K 10-Q · filed 2026-08-05 | -$141.00K derived: sum of 3 quarters · filed 2026-08-05 | $7.00M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $0.00 derived: sum of 2 quarters · filed 2026-05-05 | $7.14M derived: sum of 3 quarters · filed 2026-05-05 | $6.91M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $7.14M derived: sum of 2 quarters · filed 2026-03-19 | $6.91M derived: sum of 3 quarters · filed 2026-08-05 | $14.53M 10-K · filed 2026-03-19 | |
| 2025-09-30 | $7.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $6.91M derived: sum of 2 quarters · filed 2026-08-05 | $14.53M 10-Q · filed 2025-11-07 | $19.46M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-06-30 | -$235.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $7.38M 10-Q · filed 2026-08-05 | $12.32M derived: sum of 3 quarters · filed 2026-08-05 | $13.33M derived: sum of 4 quarters · filed 2026-08-05 | |
| 2025-03-31 | $7.62M 10-Q · filed 2026-05-05 | $12.55M derived: sum of 2 quarters · filed 2026-05-05 | $13.57M derived: sum of 3 quarters · filed 2026-05-05 | $18.83M derived: sum of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | $4.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $5.95M derived: sum of 2 quarters · filed 2026-03-19 | $11.22M derived: sum of 3 quarters · filed 2026-03-19 | $11.27M 10-K · filed 2026-03-19 | |
| 2024-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $6.28M derived: sum of 2 quarters · filed 2025-11-07 | $6.33M 10-Q · filed 2025-11-07 | $10.29M derived: sum of 4 quarters · filed 2025-11-07 | |
| 2024-06-30 | $5.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $5.32M 10-Q · filed 2025-08-08 | $9.27M derived: sum of 3 quarters · filed 2025-08-08 | $9.52M derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $49.00K 10-Q · filed 2025-05-14 | $4.00M derived: sum of 2 quarters · filed 2025-05-14 | $4.25M derived: sum of 3 quarters · filed 2025-05-14 | -$26.03M derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $3.96M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $4.21M derived: sum of 2 quarters · filed 2025-03-28 | -$26.08M derived: sum of 3 quarters · filed 2025-03-28 | -$26.08M 10-K · filed 2025-03-28 | |
| 2023-09-30 | $250.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | -$30.04M derived: sum of 2 quarters · filed 2024-11-08 | -$30.04M 10-Q · filed 2024-11-08 | -$30.04M derived: sum of 4 quarters · filed 2024-11-08 | |
| 2023-06-30 | -$30.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$30.29M 10-Q · filed 2024-08-13 | -$30.29M derived: sum of 3 quarters · filed 2024-08-13 | -$29.49M derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-15 | $1.00K derived: sum of 2 quarters · filed 2024-05-15 | $801.00K derived: sum of 3 quarters · filed 2024-05-15 | $3.83M derived: sum of 4 quarters · filed 2024-05-15 | |
| 2022-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | $801.00K derived: sum of 2 quarters · filed 2024-03-11 | $3.83M derived: sum of 3 quarters · filed 2024-03-11 | $34.06M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $3.83M derived: sum of 2 quarters · filed 2023-11-14 | $34.05M 10-Q · filed 2023-11-14 | $38.97M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $33.26M 10-Q · filed 2023-08-14 | $38.17M derived: sum of 3 quarters · filed 2023-08-14 | $41.41M derived: sum of 4 quarters · filed 2023-08-14 | |
| 2022-03-31 | $30.22M 10-Q · filed 2023-05-12 | $35.14M derived: sum of 2 quarters · filed 2023-05-12 | $38.38M derived: sum of 3 quarters · filed 2023-05-12 | $53.46M derived: sum of 4 quarters · filed 2023-05-12 | |
| 2021-12-31 | $4.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $8.15M derived: sum of 2 quarters · filed 2023-03-30 | $23.24M derived: sum of 3 quarters · filed 2023-03-30 | $70.85M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $3.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $18.32M derived: sum of 2 quarters · filed 2022-11-14 | $65.93M 10-Q · filed 2022-11-14 | $99.42M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $15.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $62.69M 10-Q · filed 2022-08-11 | $96.19M derived: sum of 3 quarters · filed 2022-08-11 | $97.81M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $47.60M 10-Q · filed 2022-05-12 | $81.10M derived: sum of 2 quarters · filed 2022-05-12 | $82.72M derived: sum of 3 quarters · filed 2022-05-12 | $120.65M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $33.49M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | $35.11M derived: sum of 2 quarters · filed 2022-03-23 | $73.04M derived: sum of 3 quarters · filed 2022-03-23 | $78.12M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $1.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $39.55M derived: sum of 2 quarters · filed 2021-11-12 | $44.63M 10-Q · filed 2021-11-12 | $44.63M derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $37.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $43.01M 10-Q · filed 2021-08-16 | $43.01M derived: sum of 3 quarters · filed 2021-08-16 | $42.90M derived: sum of 4 quarters · filed 2021-08-16 | |
| 2020-03-31 | $5.08M 10-Q · filed 2021-05-14 | $5.08M derived: sum of 2 quarters · filed 2021-05-14 | $4.97M derived: sum of 3 quarters · filed 2021-05-14 | $56.58M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-24 | -$111.00K derived: sum of 2 quarters · filed 2021-03-24 | $51.50M derived: sum of 3 quarters · filed 2021-03-24 | $65.12M 10-K · filed 2021-03-24 | |
| 2019-09-30 | -$111.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $51.50M derived: sum of 2 quarters · filed 2020-11-06 | $65.12M 10-Q · filed 2020-11-06 | $65.12M derived: sum of 4 quarters · filed 2020-11-06 | |
| 2019-06-30 | $51.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $65.23M 10-Q · filed 2020-08-10 | $65.23M derived: sum of 3 quarters · filed 2020-08-10 | $65.23M derived: sum of 4 quarters · filed 2020-08-10 | |
| 2019-03-31 | $13.61M 10-Q · filed 2020-05-11 | $13.61M derived: sum of 2 quarters · filed 2020-05-11 | $13.61M derived: sum of 3 quarters · filed 2020-05-11 | $13.70M derived: sum of 4 quarters · filed 2020-05-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $0.00 derived: sum of 2 quarters · filed 2020-03-16 | $85.00K derived: sum of 3 quarters · filed 2020-03-16 | $181.00K 10-K · filed 2020-03-16 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $85.00K derived: sum of 2 quarters · filed 2019-11-12 | $181.00K 10-Q · filed 2019-11-12 | $181.00K derived: sum of 4 quarters · filed 2019-11-12 | |
| 2018-06-30 | $85.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $181.00K 10-Q · filed 2019-08-09 | $181.00K derived: sum of 3 quarters · filed 2019-08-09 | $243.00K derived: sum of 4 quarters · filed 2019-08-09 | |
| 2018-03-31 | $96.00K 10-Q · filed 2019-05-10 | $96.00K derived: sum of 2 quarters · filed 2019-05-10 | $158.00K derived: sum of 3 quarters · filed 2019-05-10 | $150.00K derived: sum of 4 quarters · filed 2019-05-10 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $62.00K derived: sum of 2 quarters · filed 2019-03-18 | $54.00K derived: sum of 3 quarters · filed 2019-03-18 | $49.98M 10-K · filed 2019-03-18 | |
| 2017-09-30 | $62.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $54.00K derived: sum of 2 quarters · filed 2018-11-13 | $49.98M 10-Q · filed 2018-11-13 | $68.62M derived: sum of 4 quarters · filed 2018-11-13 | |
| 2017-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-13 | $49.91M 10-Q · filed 2018-08-13 | $68.56M derived: sum of 3 quarters · filed 2018-08-13 | ||
| 2017-03-31 | $49.92M 10-Q · filed 2018-05-14 | $68.57M derived: sum of 2 quarters · filed 2018-05-14 | |||
| 2016-12-31 | $18.64M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-29 | $31.63M 10-K · filed 2018-03-29 | |||
| 2016-09-30 | $12.98M 10-Q · filed 2017-11-14 | ||||
| 2015-12-31 | $3.57M 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |